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U.S. adults with end-stage renal disease. The Medical Expenditure Panel Survey, a 
representative sample of the U.S. households was utilized. End-stage renal disease 
cases with clinical classification codex value of 158 were pooled for calendar cyears 
2002 to 2011. Self-reported body mass index was classified as underweight (BMI < 
18.5), normal weight (18.50 < BMI < 24.99), overweight (25 < BMI < 29.99) and obese 
(BMI > 30). Mean annual health care use and expenditures were estimated by body 
mass index among end-stage renal disease adults. RESULTS: 1.9% of end-stager 
renal disease adults were underweight (exluded due to small sample size), 28.0% 
were normal weight, 39.0% were overweight and 31% were obese. Mean annual non-
zero hospital night stays were 25, 2, and 20 days for normal weight, overweight and 
obese end-stage renal adults. The average annual expenditures were $21672 + $4903, 
$44810 + $25906, and $71992 + 41046 among normal weight, overweight and obese 
end-stage renal disease adults. CONCLUSIONS: Obese patients had longer hospital 
stays than overweight patients and resulted in higher health care expenditures. 
End-stage renal disease patients who were obese may be more sicker. With the 
rising incidence of chronic kidney disease, overweight and obesity internationally, 
the relationship of body weight with chronic kidney disease in health care use and 
associated spending needs further exploration in larger studies.
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OBJECTIVES: Healthcare costs in the U.S. are the highest worldwide and are rapidly 
increasing. As a result of this upward trend, employers and health insurance com-
panies are trying to contain the cost of healthcare. This study aimed to understand 
and identify several factors associated with medical reimbursement amount for 
Commercial and Medicare health insurance members in Southeastern Pennsylvania 
and surrounding counties. METHODS: Using privately insured Commercial and 
Medicare health plan enrollment and claims data from 2011 and 2012 for 2 mil-
lion participants, this study empirically examined the impact of socio-demographic, 
enrollment, census data, rate relativity, utilization, risk scores and chronic diseases 
on medical reimbursement amount using risk adjustment and risk predictive models. 
The dependent variables - medical reimbursement amount, was measured separately 
as concurrent, prospective, and change variable (taking first difference) at each plan 
participant level. Regression analysis was used to examine individually and cumu-
latively how much variation was explained by different independent variables for 
Commercial and Medicare separately using adjusted R-squared. Socio-demographic 
variables included age, gender, and derived 2010 census variables at the ZIP code 
level. Separate risk scores were derived for Commercial and Medicare using DxCG’s 
all medical predicting concurrent medical risk. RESULTS: Among both Commercial 
and Medicare members, utilization (including services by inpatient, outpatient and 
professional) was the predominant predictor of medical reimbursement amount. Risk 
scores and number of chronic diseases are predictive but not as significant as utiliza-
tion in terms of explanatory power. Socio-demographic variables are important pre-
dictors but only explain a small portion of the variation. CONCLUSIONS: This study 
examined several factors associated with medical reimbursement amount. Further 
research is needed to help understand what other factors are important which may 
help shed light on potential options for ‘bending the cost curve’.
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OBJECTIVES: To describe out-of-pocket (OOP) expenditures for hospitalizations, 
ambulatory care visits and prescription medications and to determine if there is the 
difference in OOP expenditures by insurance status among subjects with Chronic 
Obstructive Pulmonary Disease (COPD). METHODS: Data for this study were drawn 
from the 2012 Medical Expenditure Panel Survey (MEPS). The sample included adults 
(≥ 18 years) with a COPD diagnosis (ICD-9 codes 491, 492, and 496) who received COPD 
services at least once in 2012. The dependent variable was annual OOP expenditures 
and the independent variable was health insurance type (private, public, or no insur-
ance). Descriptive statistics and inferential tests were conducted using SAS ProcSurvey 
for complex sampling design. RESULTS: Study subjects’ (N= 587 unweighted; 
N= 5,982,925 weighted) total mean±SE OOP COPD expenditures were $236.2±45.1 per 
person. Subjects with no insurance had total OOP expenditures ($621.3±385.9) that 
were 2.8 to 4.0 times higher than those who were privately ($221.4±22.6) or publicly 
($156.9±22.9) insured. Inpatient expenditures (N= 31 unweighted; N= 332,414 weighted) 
were significantly higher for subjects with no insurance ($4,631.7±0), and lower for 
subjects with private ($186.9±1.9) and public insurance ($105.6±4.7). Ambulatory 
care visit (N= 385 unweighted; N= 3,831,325 weighted) OOP expenditures for subjects 
with no insurance ($77.9±14.0) were over 2 times higher than OOP expenditures for 
those privately or publicly insured ($35.0±5.3; $28.2±5.6, respectively). Of those who 
had prescription expenditures (N= 468 unweighted; N= 4,906,191 weighted), patients 
with private and those with no insurance paid similar OOP amounts ($222.1±24.8; 
$224.8±61.4, respectively), while those with public insurance had lower OOP expen-
ditures ($162.5±24.4). CONCLUSIONS: When compared to subjects with private or 
public insurance, those with no insurance had higher OOP expenditures for COPD-
related total, inpatient and ambulatory care services and lower OOP expenditures 
for prescriptions. Increasing the use of appropriate COPD medications among the 
uninsured may result in cost-savings due to reduced hospitalizations.
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information regarding visual status. All-cause hospitalization was ascertained using 
Medicare claims data that were linked to MCBS. The Negative Binomial generalized 
linear model was used to quantify the relationship between VI and hospitalization 
controlling for confounding factors such as age, gender, race, income, education, 
marital status, smoking, body mass index, and chronic conditions. RESULTS: At 
baseline, 23% of beneficiaries had mild VI, and 6% had moderate-to-severe VI. Over 
time, the rate of hospitalization declined for those with mild VI or no VI, but was con-
stant for those with moderate-to-severe VI. The rate of hospitalization was higher 
in beneficiaries with moderate-to- severe VI compared with beneficiaries with no 
VI (Rate Ratio: 1.21, 95% Confidence Interval: 1.06, 1.37), adjusting for potential 
confounding variables. CONCLUSIONS: Moderate-to-severe VI was associated with 
an increased rate of hospitalization among older adults. Our results suggest that 
further research is needed to determine whether treatment of and management of 
visual impairment would be an effective measure to reduce hospitalization.
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OBJECTIVES: Depression is a major cause of increased work absentees and low pro-
ductivity increasing the total healthcare costs. Continuing to work while suffering 
from depression (presenteeism) may actually improve patient condition through col-
league support and reduce healthcare costs, however, there is not enough evidence 
to support this. The objective of this study was to compare health services utiliza-
tion and healthcare costs among employed patients with depression who engage in 
presenteeism and absenteeism. METHODS: A retrospective observational study was 
conducted using the 2011 and 2012 Medical Expenditure Panel Survey (MEPS) data. 
Adult patients (≥ 18 years) with depression were identified using ICD-9 codes (296 and 
311). All depressed patients who were employed throughout the year were assessed 
for presenteeism and absenteeism through survey responses. Logistic regressions 
were used to assess the association between absenteeism/presenteeism and office-
based visits. General linear models were used to assess the total helathcare costs 
among those who engaged in absenteeism and presenteeism. RESULTS: A total of 
1,501 adults with depression were identified. Of those, 66.7% were females. Among 
employed adults with depression, 14.7% engaged in absenteeism, while the others 
engaged in the behavior of presenteeism. After controlling for individual socio-demo-
graphic covariates, clinical comorbidities, and individual perceived health status, 
depressed patients engaging in presenteeism were 65% less likely to have more than 
three office-based visits as compared to patients engaging in absenteeism(OR: 0.349; 
95% CI: 0.235-0.518). Results for the adjusted cost analysis suggest that the behavior of 
presenteeism or absenteeism was not a significant predictor of total healthcare costs 
(p> 0.05). CONCLUSIONS: Compared to absenteeism, presenteeism among employed 
adults with depression is associated with lower health services utilization that can 
potentially be cost-saving in the long run. Employers and the medical community 
should work together for depression management among employees and reduce the 
clinical and economic burden of depression.
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OBJECTIVES: To describe and compare the first hospitalization cost and the 
readmission cost of Acute Myocardial Infarction (AMI) patients at Beijing urban 
area. METHODS: Retrospective data on hospitalization of AMI was selected from 
Beijing urban employees and residents medical insurance database. We randomly 
selected 10% of patients first diagnosed as AMI during January 2012- December 
2012and then followed those patients to September 2013 .1253 patients were 
identified in our study and then 335 patients(26.7%) reoccurred during the obser-
vation period. All information of patient demographic characters, length of stay 
and clinical costs were collected. The descriptive statistics were used. The costs 
of 2013 were converted into 2012 year price with discount rate 3.5%. RESULTS: We 
analyzed the 335 patients with recurrence of AMI,(mean age 66.14±15.04 years; 
82.39% male), among which 100 patients were readmitted to hospital over three 
times. The median followed time was 14.17(IQR11.35-18.37, mean 14.29±4.68, ) 
months. The median hospitalization cost was ¥32,148.42(IQR14303.28-68264.97, 
mean 42,905.99±36,473.35)at the first time, ¥29,189.83(IQR12111.81-64323.44, mean 
41281.34±34909.03)at the second time, and ¥25,386.72(IQR13751.55-49162.27, mean 
34859.87±30294.72) at the third time or more, respectively (p< 0.05) . The median 
length of stay was 11 days (IQR 7-16, mean 13.75±11.34days) in the first hospitali-
zation,11 days (IQR 7-16, mean 13.91±12.67,)in the second hospitalization, and 13 
days (IQR 9-19, mean 16.12±12.97days)in the third hospitalization or more ,respec-
tively. (p< 0.05) CONCLUSIONS: Patients with readmission took a relatively high 
percentage of all AMI hospitalized patients and caused heavy cost. Readmissions 
over three times had lower cost and longer length of hospital stay than the first 
and second hospitalization.
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OBJECTIVES: Chronic kidney disease, overweight and obesity are growing public 
health challenges in the U.S. with large financial implications. To examine health-
care utilization and expenditures among end-stage renal disease population by 
body mass index. METHODS: This was a retrospective cross-sectional study of 225 
